Progyny, Inc. (PGNY)

$35.83

-0.46 (-1.27%)
Rating:
Recommendation:
-
Symbol PGNY
Price $35.83
Beta 1.669
Volume Avg. 0.72M
Market Cap 3.299B
Shares () -
52 Week Range 25.67-68.32
1y Target Est -
DCF Unlevered PGNY DCF ->
DCF Levered PGNY LDCF ->
ROE 17.11% Buy
ROA 9.85% Neutral
Operating Margin -
Debt / Equity 48.82% Neutral
P/E 85.31 Strong Buy
P/B 10.59 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PGNY news


Mr. David Schlanger
Healthcare
Health Information Services
NASDAQ Global Select

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.